New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

Michael David Chuong, MD, discusses how SBRT has become a leading option for treating patients with colorectal liver ...

For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by ...

The family thought they had finally cracked the impossible puzzle of modern parenting: a trusted grandma watching the kids so ...

Genentech's PD-L1 inhibitor combined with Avastin and chemo improved median progression-free survival by around 20 months ...

Colorectal cancer cases are rising among people under 50. While cancer can happen to anyone — and the cause is often unknown ...

Regular walking during recovery may reduce cancer-related fatigue and improve long-term well-being for patients with ...

According to a 2025 survey conducted by the Prevent Cancer Foundation, only 51% of U.S. adults 21 and older say they have had ...

Millions remain unscreened for colorectal cancer. Learn how noninvasive screening can expand access, preserve capacity, and ...

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...

Guardant Health, Inc., a leading precision oncology company, today announced its Shield blood test for colorectal cancer screening is now covered for active-duty service members and their families ...

Regular physical activity—especially walking—can significantly reduce fatigue among people with colon cancer, a new study ...